Alkermes Enters Sleep Medicine Arena with USD 2.1 Billion Acquisition of Avadel
Alkermes plc has announced it will acquire Avadel Pharmaceuticals in a deal valued at up to USD 2.1 billion, marking the company’s strategic entry into the sleep medicine market.
Sleep Medicine Arena Avadel | 24/10/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy